Table 1: Baseline demographic and clinical characteristics and baseline thromboembolic and hemorrhagic risk profiles.
| All (N = 78) | Men (N = 43) | Women (N = 40) | p-value | |
| Age in years (median and IQR) | 77.8
[68.2 81.3] |
75.2
[66.0 79.6] |
78.4
[74.6 81.9] |
0.022 |
| Paroxysmal AF | 25 (32.1%) | 13 (31.7%) | 12 (32.4%) | 0.945 |
| Permanent AF | 52 (66.7%) | 28 (68.3%) | 24 (64.9%) | 0.748 |
| Comorbidities | ||||
| Arterial hypertension | 70 (89.7%) | 37 (90.2%) | 33 (89.2%) | 0.878 |
| Diabetes mellitus | 40 (51.3%) | 17 (41.5%) | 23 (62.2%) | 0.068 |
| Patient history | ||||
| Previous PCI | 6 (7.7%) | 3 (7.3%) | 3 (8.1%) | 0.954 |
| Previous stroke | 18 (23.1%) | 8 (19.5%) | 10 (27.0%) | 0.432 |
| Previous stroke during OAC | 10 (12.8%) | 4 (9.8%) | 6 (16.2%) | 0.341 |
| Previous IHD | 18 (23.1%) | 10 (24.4%) | 8 (21.6%) | 0.772 |
| Previous CHF | 25 (32.1%) | 14 (34.1%) | 11 (29.7%) | 0.676 |
| Baseline embolic and bleeding risk profile | ||||
| CHADS2 (median [IQR]) | 3 [2 - 4] | 3 [2 - 4] | 3 [2 - 4] | 0.590 |
| CHA2DS2-VASc (median [IQR]) | 5 [3 - 5] | 4 [3 - 5] | 5 [4 - 6] | 0.005 |
| HAS-BLED (median [IQR]) | 4 [3 - 5] | 4 [3 - 5] | 4 [3 - 4] | 0.465 |
Values are expressed as Number (percentage) unless otherwise indicated.
CHF: Congestive heart failure; CVA: Cerebrovascular accident; IHD: Ischemic heart disease; IQR: interquartile range; OAC: Oral anticoagulant; PCI: Percutaneous cardiac intervention.